Stereotaxis STXS
NYSE STXS
$0.83 -0.02 (-2.35%)
At close: Nov 13, 2026 · 4:00 PM EST

Stereotaxis (STXS) Receivables - Other (2017 - 2026)

Updated

Stereotaxis (STXS) reported Receivables - Other of $6.32 million for Q2 2026, up 46.3% from the prior quarter.

Analysis

Stereotaxis (STXS) Receivables - Other (2017 - 2026) Analysis & Trends

At the end of FY2025, Stereotaxis posted Receivables - Other of $4.32 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Stereotaxis 83.17 Mn 83.17 Mn 3.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.32 Mn
Mar 31, 2026 4.32 Mn
Dec 31, 2025 4.32 Mn
Dec 31, 2019 168,445.00
Dec 31, 2018 251,867.00
Mar 31, 2017 2,917.00
API Access

Stereotaxis Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=STXS&period=max&api_key=YOUR_API_KEY